| Item | Content |
|---|---|
| Rating | Cautiously Bullish |
| Target Price | HKD 95–105 (base-case fair value, SOTP basis) |
| Current Price | HKD 77.70 (closing price on 2026-08-31) |
| Margin of Safety | Approx. +22% (based on base-case fair value floor of HKD 95) |
| Time Horizon | 12–18 months |
| Valuation View | undervalued |
ANTA Sports is the absolute leader in China's sportswear market (23.0% share per Euromonitor 2024). In 2026H1, revenue reached RMB 43.51 billion (+12.9%), a record for the period; adjusted net profit was RMB 7.23 billion (+9.6%); operating margin rose to 27.0%. Yet at the current price of HKD 77.70 (2026-08-31 close), after stripping out the fair value of the Amer stake of RMB 50.8 billion and net cash of RMB 39.1 billion, the market is pricing the core business at only about RMB 96.4 billion (roughly 7.2x FY2026E adjusted net profit) — at a 9% required return, this implies core earnings shrinking about 5% per year in perpetuity, which clearly contradicts fundamental reality. Constraints: the main brand's slowdown is already a fact (only +4.8% in 2026H1, with Q2 offline retail sales declining year-over-year); the PUMA acquisition (RMB 12.3 billion consideration, ~60% premium) has yet to be validated by results; and the Hong Kong consumer discount lacks a forced convergence mechanism. Base-case fair value is HKD 95–105, with a probability-weighted expectation of about HKD 97.5 (roughly +25.5% vs. current price) — a deployable window of "undervaluation + trackable catalysts," not an unconditional buy.
Upcoming changes: ① The 29.06% stake in PUMA SE moves from "signed, pending completion" to closing (company plans within 2026, subject to regulatory approval), which will reduce net cash from RMB 39.1 billion to about RMB 26.8 billion; ② Inflection point for main brand/FILA growth to be verified — the 2026Q3 retail sales announcement (expected mid-October) is the key milestone; ③ JACK WOLFSKIN's revival plan lands at retail in 2026H2, coinciding with the peak season for premium outdoor.
Primary share price driver: Retail sales growth of the main brand and FILA (together about 75% of 2026H1 revenue). The market's biggest current disagreement is not direction but magnitude: the latest sell-side target price range is HKD 102.5–125 (BofA at 102.5 and UBS at 104.5 are the most cautious; Macquarie/Nomura at 125 the most optimistic), while the current price, reverse-engineered via SOTP, implies zero growth or even contraction for the core business.
Verifiable expectation gap: The current price embeds a "core business decline + holding-company discount" pricing, yet 2026H1 revenue +12.9%, adjusted net profit +9.6%, gross margin 63.9% (+0.5pp), and free cash flow +54.2% do not support the decline hypothesis. But honesty requires acknowledging: this expectation gap is a "divergence between facts and pricing" rather than "facts the market doesn't know" — the market's concerns about the main brand's offline negative growth and PUMA integration risk have real grounds. The expectation gap status is mixed (partly narrative, partly verifiable).
Validation catalysts and falsification conditions: Upside catalysts are PUMA closing (2026Q4), a Q3 retail sales inflection, and Amer's Q3 results (mid-November); falsification triggers are two consecutive quarters of negative main-brand retail sales growth, failure to close PUMA or integration-related impairments, or FILA's operating margin falling below 26%.
Key evidence:
The structural issue that must be called out: other brands account for only 24.6% of group revenue yet contributed about 66% of the group's revenue increment (increment of about RMB 3.28 billion vs. group increment of about RMB 4.96 billion) — the so-called "hedge" is really a shift in growth concentration. If other brands' growth falls from 44% to 20%, group growth would drop toward high single digits; moreover, the segment's operating margin has already slipped 0.1pp year-over-year, and JW is in the early stage of its revival — its rising share of consolidation is dilutive to segment margins.
Key evidence:
Multi-year OCF/net profit in the 1.07–1.92 range and FCF/net profit 0.85–1.74 — book profits convert almost fully into freely disposable cash, and CapEx/depreciation has long been below 1: a classic cash cow. But two corrections: net cash of RMB 39.1 billion will fall to about RMB 26.8 billion (-31%) after the PUMA closing; if the share price stays below the CB conversion price (about HKD 97.8–99.8) in 2029, cash repayment of about RMB 11.7 billion principal would be required; and the 2026H1 annualized ROE of 27.8% is inflated by the one-off gain from the Amer placement — on a sustainable basis it is about 20%.
Key evidence:
The base-case fair value of HKD 95–105 already applies a 10% minority-interest/liquidity discount to the Amer stake and values PUMA at cost with zero synergy premium, still leaving about a 22% margin of safety versus the current price. But two constraints must be acknowledged: first, the roughly RMB 33.1 billion premium between Amer's fair value and book value depends entirely on Arc'teryx/Salomon's high growth materializing — this stake's fair value already shrank about RMB 7.3 billion in 2026H1, and under a -20% sensitivity, the asset floor drops from HKD 37.5/share to about HKD 33; second, the Hong Kong holding-company discount can persist for years without repair, and this thesis lacks a forced convergence mechanism (no offer/privatization/special dividend arrangement) — valuation repair requires fundamental catalysts (retail sales inflection, PUMA closing) rather than natural convergence.
Key evidence:
The positives are equally real: ANTA has two successful integration records (FILA, Amer); the share price surge after the PUMA announcement shows the market endorses the deal logic; and PUMA's global channels are complementary to ANTA's supply chain and Southeast Asia/China channels. The closing itself (2026Q4) is a catalyst; integration failure or failure to close by end-2026 is the main downside risk.
Key evidence:
Based on estimated FY2026E dividend of about HK 270 cents per share, the dividend yield is about 3.5%. Note the competing uses of capital: the PUMA closing (RMB 12.3 billion) plus potential CB repayment (RMB 11.7 billion) share the same balance sheet as dividends and buybacks — if PUMA integration consumes more than expected, the payout ratio and buybacks could be cut.
Key evidence:
The quarterly retail sales trajectory (2025Q3 low single-digit positive → Q4 negative → 2026Q1 high single-digit positive → Q2 low single-digit positive) shows the main brand's growth center has systematically shifted down to low single digits, and the structure of online-driven growth with offline negative growth is weaker than headline numbers suggest. If 2026Q3/Q4 retail sales show no improvement, group growth will depend entirely on other brands (less than a quarter of revenue) and Amer delivering, and the valuation framework risks sliding from "consumer blue chip" to "conglomerate holding discount."
| Metric (RMB million) | FY2023 | FY2024 | FY2025 | 2025H1 | 2026H1 |
|---|---|---|---|---|---|
| Revenue | 62,356 | 70,826 | 80,219 | 38,544 | 43,507 |
| YoY | — | +13.6% | +13.3% | — | +12.9% |
| Net profit attributable to shareholders | 10,236 | 15,596 | 13,588 | 7,031 | 9,487 |
| Adjusted net profit | 10,950 | 11,729 | 12,385 | 6,597 | 7,230 |
| Gross margin | 62.6% | 62.2% | 62.0% | 63.4% | 63.9% |
| Net margin (attributable) | 16.4% | 22.0% | 16.9% | 18.2% | 21.8% |
| Operating cash flow | 19,634 | 16,741 | 20,996 | — | 13,081 |
| Free cash flow | 17,823 | 13,254 | 16,106 | 7,542 (restated) | 11,630 |
| Cash + cash-like assets | — | — | 55,021 | — | 62,601 |
| Interest-bearing debt | — | — | 23,302 | — | 23,488 |
| Net cash | — | — | 31,719 | — | 39,113 |
| Inventory turnover days | 123 | 123 | 137 | 136 | 130 |
| ROE | — | 27.6% | 21.3% | — | 27.8% (annualized) |
Note: Cross-period swings in attributable net profit and net margin were driven by one-off gains from Amer Sports (FY2024 included RMB 3.669 billion; 2026H1 included RMB 1.549 billion of placement dilution gains) — cross-period comparisons should use the adjusted basis (FY2025 +5.6%, 2026H1 +9.6%). Balance sheet stock figures are as of 2026-06-30. The gearing ratio was not verified against the source text and is not cited.
Revenue of RMB 43.507 billion (+12.9%) fits the "multi-brand hedge" logic: main brand +4.8%, FILA +6.1%, other brands +44.2%. Attributable net profit of RMB 9.487 billion (+34.9%) looks impressive on the surface, but RMB 1.549 billion of it was a one-off equity dilution gain from the Amer placement; excluding it, growth was +12.9% to RMB 7.938 billion; adjusted net profit was RMB 7.230 billion (+9.6%) — profit growth lagging revenue growth, mainly because the ANTA segment's operating margin fell 0.8pp (brand and globalization investments), partly offset by expense leverage lifting the overall operating margin +0.7pp to 27.0%. Market reaction: the stock surged 9.53% on results day (August 26), then fell back to HKD 77.70 (August 31 close); 32 analysts' consensus for 2026 full-year revenue is about RMB 88.2 billion (about +10%) — the results broadly met sell-side expectations, and the market's pricing disagreement lies not in this period's results but in the main brand's trend and PUMA's prospects.
Business model: A multi-brand sporting goods group spanning mass-market professional sports (ANTA main brand, hybrid DTC + wholesale + e-commerce), mid-to-high-end sports fashion (FILA, fully direct-operated), and premium professional outdoor (DESCENTE/KOLON/JACK WOLFSKIN), with a global footprint via a 37.63% stake in Amer Sports (Arc'teryx/Salomon, equity method, not consolidated). Revenue is goods-sales-based, not recurring subscription, but the multi-brand matrix plus DTC direct retail confer strong pricing power and channel control: the group's 62–64% gross margin is among the industry's highest.
Cash conversion of earnings: OCF/attributable net profit FY2023 1.92 → FY2024 1.07 → FY2025 1.55 → 2026H1 1.38; FCF/attributable net profit 1.74 → 0.85 → 1.19 → 1.23. Long-term levels are well above the 0.8/0.5 warning thresholds — excellent cash conversion of book profits; in 2026H1, revenue grew +12.9% while working capital was released net (inventory -RMB 1.80 billion, receivables -RMB 0.83 billion) — growth requires no capital tie-up. Recurrence check: the entire gap between adjusted and attributable net profit comes from Amer one-off gains (FY2024 gap RMB 3.87 billion, 2026H1 gap RMB 2.26 billion, both exceeding ±15%); the company's adjusted measure excludes associate gains/losses and one-off items, which is a reasonable definition; note that this measure also excludes the PUMA equity-method share of losses — "adjusted net profit +9.6%" does not include the PUMA drag.
Return on capital: FY2025 estimated ROIC of about 15.3% (return on operating capital is significantly higher after excluding the large net cash position), ROE about 20% (sustainable basis), above WACC — a genuine moat signal.
Maintenance CapEx: CapEx/depreciation FY2024 0.63, FY2025 0.43, far below the 1.5 capital-black-hole warning threshold — clearly an asset-light retail operation.
Red flags: Rising dependence of profit structure on investment income — in 2026H1, share of associates' net profit of RMB 708 million plus the Amer dilution gain of RMB 1.549 billion together accounted for about 15.5% of pre-tax profit; core operating profit and investment income should be valued separately. Customer/supplier concentration is extremely low (top five customers 7.3%, top five suppliers 14.6%) — no concentration risk.
Consistency of words and deeds: ① The FY2025 annual report set a target of DESCENTE retail sales exceeding RMB 10 billion — confirmed achieved in the FY2025 annual report, with KOLON the group's fastest-growing brand (delivered); ② The FY2024 annual report pledged "maintaining stable and healthy inventory and discount levels in 2025" — inventory turnover days actually rose to 137 (+14 days), only falling back to 130 in 2026H1 (partially delivered); ③ The FY2025 annual report proposed completing the PUMA acquisition within 2026 — not completed as of 2026H1, with the interim report reaffirming the within-year plan (in progress). Overall judgment: pragmatic-leaning; no quantitative revenue/profit guidance, all outlook statements qualitative, historical guidance conservative and steady — but the high-profile main brand goal of "surpassing Nike China in 3 years" has receded with the departure of its lead executive, impairing credibility of brand-level targets.
Shareholder friendliness: Payout ratio steady at about 50% for years (FY2024 51.4%, FY2025 50.1%, 2026H1 interim 50.3%); DPS increased for five consecutive years (134→197→236→245 HK cents); 2024–2025 cumulative buyback and cancellation of about 36 million shares (HKD 2.96 billion), no dilution from new share placements. Judgment: shareholder-friendly. Deduction: a precedent of a discounted placement of 88 million shares at a market high in 2021, raising HKD 11.57 billion — the family shows path dependence on refinancing at share price highs.
Risk signals: Family control of about 53% of shares (Ding Shizhong, Ding Shijia, Lai Shixian) — major capital allocation decisions (e.g., PUMA) are family-led with limited checks from minority shareholders; related-party transactions are small and capped (packaging materials purchased from family directors of RMB 91 million in 2025, about 0.11% of revenue; OEM sales/purchases with Amer totaling about RMB 570 million per half-year); five brand executive changes within one year are a real risk signal for execution continuity.
| Segment | Revenue (RMB bn) | Share | YoY | Gross Margin | Operating Margin | Business Logic |
|---|---|---|---|---|---|---|
| Anta Main Brand | 17.77 | 40.8% | +4.8% | 55.1% | 22.5% | Mass professional sports base, DTC + e-commerce + wholesale |
| FILA | 15.05 | 34.6% | +6.1% | 67.8% | 28.7% | Premium sports fashion, fully direct-operated, middle-class consumption |
| All Other Brands | 10.69 | 24.6% | +44.2% | 73.1% | 33.1% | DESCENTE/KOLON/JW premium outdoor, growth engine |
| Associate Amer Sports | Not consolidated | — | Revenue +24.4% | Not disclosed | — | 37.63% equity method, Arc'teryx/Salomon |
Profit Drivers: Estimated by revenue share × operating margin, the Anta main brand contributes ~RMB 4.00 bn of segment operating profit, FILA ~RMB 4.32 bn, and other brands ~RMB 3.54 bn — FILA, with 34.6% of revenue, contributes the largest segment operating profit and remains the top profit pillar; other brands, with 24.6% of revenue, contribute ~28% of segment operating profit, with their profit weight approaching that of the main brand. The gap between the highest gross margin structure (other brands, 73.1%) and the lowest (main brand, 55.1%) is 18pp, reflecting the divergence between the pricing power of premium outdoor functional products and price competition in the mass market — a micro-level mapping of the industry's stratified prosperity.
Accounting Red Flags: ① Sudden reversal in inventory write-down direction (severity: low) — in FY2025, inventory write-downs of RMB 274 mn were charged to P&L, versus a reversal of RMB 132 mn in FY2024, a swing of ~RMB 400 mn, moving in the same direction as FY2025 inventory +12.9%; watch subsequent net realizable value. Beyond this, no obvious accounting manipulation was found in revenue recognition, impairment provisions, etc.
Cross-Period Consistency:
Current Market Data: Share price HK$77.70 (closing price on 2026-08-31), market cap ~HK$217.3 bn (~RMB 186.3 bn), total shares ~2.797 bn. PE(TTM) 11.76x, PB 2.63x, both at the 0% percentile over the past 1/3/5/10 years (historical lows, deterministically computed by the valuation series tool) — but TTM reported net profit includes Amer one-off gains, so the percentile is for reference only, not a headline cheap/expensive signal; forward PE (FY2026E adjusted) ~13.8x, PEG ~1.4 (consolidated basis) / 0.74 (core business basis).
Peer Comparison:
| Company | PE | PB | Revenue Growth | ROE | Difference vs Anta |
|---|---|---|---|---|---|
| Anta Sports | 13.8x (forward) | 2.63 | +12.9% (2026H1) | ~20% | — |
| Li Ning | 10.2x | 1.07 | +3.2% (2025) | 10.9% | Single brand, net profit declining three years straight |
| Xtep International | 7.0x | 0.83 | +4.2% (2025) | 14.5% | Mass running, wholesale-driven |
| 361 Degrees | 6.2x | 0.75 | +10.6% (2025) | 13.5% | Lower-tier markets, ~1/7 the size |
| Nike | 18.6x | — | Greater China declining for years | 22.1% | Global brand but losing momentum in China |
| lululemon | 10.2x | — | Global +5–7% | 34.0% | Single category, high-margin DTC |
Market-Implied Expectations: The current price implies the market believes core business (Anta main brand + FILA + other brands) earnings are near zero growth or even in perpetual decline (~-5%/year at a 9% required return), whereas reality shows revenue +12.9%, adjusted net profit +9.6%, and rising operating margins. What the market is actually paying for is a combination of "Amer stake discount + PUMA integration risk premium + Hong Kong-listed consumer sector systemic discount," not a pricing of fundamentals — BofA explicitly noted on 2026-07-21 that "the current 13x 2026 PE does not reflect the value of the Amer stake."
Three-Layer Value: ① Asset floor HK$37.5/share = net cash 16.3 (RMB 39.1 bn) + Amer stake fair value 21.2 (RMB 50.8 bn, at full market value; with a -20% sensitivity on the stake, the floor is ~HK$33); ② Core EPV HK$62.4/share (system-computed as normalized EPS HK$5.62 ÷ WACC 9%, corresponding to zero-growth going-concern value; ~HK$56 at WACC 10%); ③ Growth option (high outdoor growth, globalization, PUMA synergies) is negatively priced at the current level — the current price of HK$77.70 is ~22% below the combined "asset layer + core EPV" of HK$100. The current price is mainly supported by the discounted asset layer and EPV.
Three Scenarios and Odds:
| Scenario | Fair Range (HK$) | Probability | Key Drivers |
|---|---|---|---|
| Bear | 55–65 | 25% | Main brand revenue turns negative + FILA zero growth + price war: core adjusted net profit falls to ~RMB 10 bn, priced at 7x (benchmark: lower end of Li Ning/Xtep); Amer fair value retraces to RMB 40 bn; PUMA impaired to RMB 9 bn; net cash of RMB 26.8 bn after deducting PUMA settlement payment |
| Base | 95–105 | 50% | Core earnings sustain high-single-digit growth: FY2027E adjusted net profit ~RMB 14.6 bn × 10–11x (anchor: conservative take between own 3-year static PE median of 15.9x and 10-year median of 26.7x; peer median of 6–10x used only as bear-case anchor) + Amer fair value at 10% discount, HK$19.1 + post-settlement net cash HK$11.2 + PUMA at cost HK$5.1 |
| Bull | 125–135 | 25% | High outdoor growth + PUMA synergies delivered: 2028 core adjusted net profit ramps to ~RMB 16.5 bn × 13x (anchor: discount to Nike's current 18.6x); Amer recovers to RMB 60 bn; PUMA synergies re-rated to RMB 18 bn |
The current price of HK$77.70 falls between the bear-case ceiling and the base-case floor, and significantly below the probability-weighted expectation of ~HK$97.5 (+25.5% vs current): upside to base-case midpoint is ~+29%, to base-case upper bound ~+35%; downside to bear-case floor is ~-29%. The odds skew upward but not asymmetrically enough to ignore the bear case — the ~-29% downside at the bear case's 25% probability is comparable to the base-case upside. Anchoring of the base-case exit multiple at 10–11x: a steep discount to the own 10-year median of 26.7x, a premium to the peer median (6–10x), justified by the quality gap of ~20% ROE vs Li Ning's 11% and the multi-brand matrix; if main brand growth falls below zero, that premium collapses — this is the most fragile assumption in the base case. Sell-side target price range: HK$102.5 (UBS, most conservative) – HK$125 (Macquarie/Nomura); this report's base range is slightly below the most conservative sell-side figure, as we apply a 10% discount to the Amer stake and value PUMA at cost with zero synergies.
In-House Earnings Forecasts (alongside management guidance and sell-side consensus):
| Period | Revenue | Adjusted Net Profit | Key Assumptions |
|---|---|---|---|
| FY2026E | RMB 87.0–89.0 bn (+8.5–11%) | RMB 13.2–13.8 bn (+7–11%) | Main brand +3–5%, FILA +5–7%, other brands +30–35%; operating margin ~27%, flat to slightly up |
| FY2027E | RMB 94.0–98.0 bn (+8–10%) | RMB 14.2–15.2 bn (+7–10%) | Outdoor sustains high growth + JW full rollout + 1,000 stores in Southeast Asia; PUMA equity-method share (RMB 300–500 mn magnitude, in reported but not adjusted figures) |
Management gives no quantitative guidance (qualitative outlook: "big and steady, high growth in sub-segments"); sell-side consensus for 2026 revenue is ~RMB 88.2 bn, and CLSA's brand-level forecasts (+3%/+6%/+35%) broadly align with this report's assumptions.
Conclusion: Undervalued. Target price HK$95–105 (base-case fair value), safety margin ~+22% (base-case floor basis). Assess quality and price separately: quality is excellent (62–64% gross margin, ~20% ROE, cash cow, multi-brand moat), price is cheap (core business implied at 7.2x, PB at historical low percentile), but the reasons for cheapness (main brand stalling, PUMA uncertainty, HK discount) are real, and a re-rating requires catalysts.
Industry Size: China's sportswear market was ~RMB 542.5 bn in 2024 (iiMedia Research retail sales basis); Euromonitor basis showed ~+5.9% YoY in 2024 — aggregate growth has slowed from the mid-to-high single digits of the past decade, entering maturity. The next 3–5 years are expected to see 5–7% CAGR, with structural increments from the premium outdoor functional segment (double-digit growth) and lower-tier markets; on the policy side, the 2030 target for total sports industry output exceeds RMB 7 trillion (General Office of the State Council). Prosperity within the industry is sharply stratified: the mass price band faces "slowing growth + discount competition," while premium outdoor sees volume and price rising together (Amer 2025 revenue +27%, Arc'teryx segment +30%, DESCENTE retail sales topping RMB 10 bn).
Value Chain and Value Distribution: Upstream textile fabrics and footwear materials OEM (Shenzhou International, Huali, etc., gross margins 20–30%, weak bargaining power) → midstream brand owners (thickest margin link; Anta Group gross margin 62–64%, FILA 66–68%) → downstream retail channels (DTC direct/wholesale/e-commerce). Anta occupies a "brand owner + retail integration" position: its DTC reform internalizes channel margins, it holds strong bargaining power over upstream OEMs (ample capacity, relocatable to Southeast Asia), and it wields brand pricing power over end consumers — value is retained mainly in the "brand + direct retail" links, which is the structural reason Anta's gross margin leads peers.
Supply-Demand and Competitive Structure: CR5 ~70% (Euromonitor 2024), concentrated at the top and still rising. Euromonitor shares: Anta rose from 15.3% in 2019 to 23.0% in 2024 (No. 1); Nike China slid continuously from 25.2% in 2021, ceding the top spot; adidas China fell from 14.8% to a marked decline before stabilizing and recovering (11 consecutive quarters of positive growth in 2025); Li Ning ~8–10%. Entry barriers: top-tier sports marketing resources (Olympics/national teams) locked up by leaders, nationwide DTC network operational capability, R&D technology platforms (Nitrogen technology), multi-brand M&A integration capability. Competitive intensity: discount competition in the mass price band has become the norm (Xtep's financial report explicitly cites industry-wide deepening discounts); new entrants (On, HOKA, Salomon) are disrupting mid-to-high-end niches; the premium outdoor price band remains undersupplied.
Cycles and Regulation: The industry is in a weak-prosperity mature phase; leading indicators are each brand's retail sales growth, sell-through ratio (healthy range 3–5 months), discount depth, and new-product sell-through rates. The regulatory/policy environment is broadly friendly: the Special Action Plan to Boost Consumption (2025-03), the 2030 RMB 7 trillion sports industry target (2025-09), the NDRC's first batch of 49 high-quality outdoor sports destinations (2026-02), and the National Fitness Plan (2026–2030) (2026-07); the guochao (national trend) mindset dividend from the 2021 Xinjiang cotton incident persists, but foreign brands have partially recovered, and substitution has entered a stalemate phase.
Company's Industry Position: The absolute leader with still-rising share — 2025 revenue of RMB 80.2 bn exceeds the sum of Li Ning + Xtep + 361 Degrees; the moat comes from a multi-brand full-price-band matrix (structural advantage over single-brand rivals), DTC retail operational capability (industry benchmark for gross margin and sell-through ratio), and global footprint (Amer as the second growth curve). Risk points: main brand growth slowing with declining operating margin, and the mass price band facing a double squeeze from Nike China's price cuts to win back customers (medium-term risk) and white-label discounting.
In sportswear, the decisive battleground is not reported profit but channel health — retail sales growth, sell-through ratio, and discount discipline determine earnings sustainability.
Brand-by-Brand Retail Sales Trajectory (by retail value):
| Quarter | Anta Main Brand | FILA | Other Brands (ex-JW) |
|---|---|---|---|
| 2025Q3 | Low-single-digit positive | Low-single-digit positive | +45–50% |
| 2025Q4 | Low-single-digit negative | Mid-single-digit positive | +35–40% |
| 2026Q1 | High-single-digit positive | Low end of 10–20% | +40–45% |
| 2026Q2 | Low-single-digit positive | Low-single-digit positive | +25–30% |
Channel Health: Group sell-through ratio ~5 months (upper end of the healthy 3–5 month range), 2026H1 average inventory turnover days 130 (-6 days YoY), inventory -14.8% vs the start of the year — no sign of a 2012–2013-style inventory crisis; e-commerce accounts for 35.7% of group revenue (2026H1, +15.7%), DTC ~50%. Peer comparison: Li Ning's omni-channel sell-through ratio is ~4 months but net profit has declined three years straight; Anta, with the combination of "slightly higher sell-through ratio + rising margins," still sets the industry benchmark for channel quality. Warning signals to watch: main brand growth reliant on e-commerce (offline retail sales declining), other brands' retail sales growth decelerating quarter by quarter (45–50%→25–30%), and industry-wide deepening discounts — if all three converge, they will show up in the 2026Q4–2027 retail sales announcements before hitting the income statement.
Overall Assessment: Cautiously bullish, confidence 0.60, time horizon 12–18 months. Anta is a rare HK-listed consumer leader where quality and price are both favorable: the core business is priced at zero growth/recession, while the multi-brand engine, cash conversion capability, and shareholder returns all support a higher valuation. It is "cautious" rather than "bullish" because three constraints are real: main brand stalling is the current state (negative offline growth + executive churn), PUMA's RMB 12.3 bn consideration synergies are unproven, and the HK discount lacks a forced convergence mechanism — valuation repair requires fundamental catalyst confirmation around 2026Q4, not automatic occurrence.
Strategy: The current price offers allocation value with a ~22% safety margin; aggressive investors can build positions in tranches within the HK$77–80 range, while conservative investors can wait for one of two validation signals (Q3 retail sales showing main brand recovery to mid-to-high single digits, or smooth PUMA settlement) before adding. If the share price rises above HK$95 (base-case floor), the safety margin is exhausted and upside needs re-evaluation; a fall below HK$65 (bear-case floor) would indicate the market is pricing in deterioration we have not seen, warranting re-examination rather than mechanical averaging down.
Risk Disclosures: Main brand retail sales negative for two consecutive quarters (falsifies the base case); PUMA settlement failure or integration impairment (impairment expectations of RMB 2.5–3.7 bn could compress the valuation center by 10–15%); Amer stake fair value volatility (~27% of market cap; -20% means ~RMB 10 bn loss); the 2029 convertible bonds require ~RMB 11.7 bn cash repayment if not converted; weak macro consumption and industry price war; FX (dual USD/EUR exposure).
Catalyst Calendar:
Key Citation List: